MKI67 and Lynch syndrome: The result of Ki67 expression demonstrated that vaccine, PD-1 antibody, and combination therapy treatment could reduce the level of tumor cell proliferation in Lynch syndrome, and combination therapy acted the best effect (Figures 5A,B).